-
Novel vaccine technique shows promise in Phase I trial of advanced chronic lymphocytic leukemia
News and Views: Clinical Investigation
-
Novel vaccine technique shows promise in Phase I trial of advanced chronic lymphocytic leukemia
News and Views: Clinical Investigation
-
Novel vaccine technique shows promise in Phase I trial of advanced chronic lymphocytic leukemia
News and Views: Clinical Investigation
-
Novel vaccine technique shows promise in Phase I trial of advanced chronic lymphocytic leukemia
News and Views: Clinical Investigation
-
Novel vaccine technique shows promise in Phase I trial of advanced chronic lymphocytic leukemia
News and Views: Clinical Investigation
-
Novel vaccine technique shows promise in Phase I trial of advanced chronic lymphocytic leukemia
News and Views: Clinical Investigation
-
Novel vaccine technique shows promise in Phase I trial of advanced chronic lymphocytic leukemia
News and Views: Clinical Investigation
-
Novel vaccine technique shows promise in Phase I trial of advanced chronic lymphocytic leukemia
News and Views: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Src tyrosine kinase inhibitors in the treatment of lung cancer: rationale and clinical data
Sacha I Rothschild,Oliver Gautschi
Therapeutic Perspective: Clinical Investigation
-
Src tyrosine kinase inhibitors in the treatment of lung cancer: rationale and clinical data
Sacha I Rothschild,Oliver Gautschi
Therapeutic Perspective: Clinical Investigation
-
Src tyrosine kinase inhibitors in the treatment of lung cancer: rationale and clinical data
Sacha I Rothschild,Oliver Gautschi
Therapeutic Perspective: Clinical Investigation
-
Src tyrosine kinase inhibitors in the treatment of lung cancer: rationale and clinical data
Sacha I Rothschild,Oliver Gautschi
Therapeutic Perspective: Clinical Investigation
-
Src tyrosine kinase inhibitors in the treatment of lung cancer: rationale and clinical data
Sacha I Rothschild,Oliver Gautschi
Therapeutic Perspective: Clinical Investigation
-
Src tyrosine kinase inhibitors in the treatment of lung cancer: rationale and clinical data
Sacha I Rothschild,Oliver Gautschi
Therapeutic Perspective: Clinical Investigation
-
Src tyrosine kinase inhibitors in the treatment of lung cancer: rationale and clinical data
Sacha I Rothschild,Oliver Gautschi
Therapeutic Perspective: Clinical Investigation
-
Src tyrosine kinase inhibitors in the treatment of lung cancer: rationale and clinical data
Sacha I Rothschild,Oliver Gautschi
Therapeutic Perspective: Clinical Investigation
-
Moving forward: putting research into practice
Liselotte Hojgaard
Commentary: Clinical Investigation
-
Moving forward: putting research into practice
Liselotte Hojgaard
Commentary: Clinical Investigation
-
Moving forward: putting research into practice
Liselotte Hojgaard
Commentary: Clinical Investigation
-
Moving forward: putting research into practice
Liselotte Hojgaard
Commentary: Clinical Investigation
-
Moving forward: putting research into practice
Liselotte Hojgaard
Commentary: Clinical Investigation
-
Moving forward: putting research into practice
Liselotte Hojgaard
Commentary: Clinical Investigation
-
Moving forward: putting research into practice
Liselotte Hojgaard
Commentary: Clinical Investigation
-
Moving forward: putting research into practice
Liselotte Hojgaard
Commentary: Clinical Investigation
-
Drug-eluting balloons: where are we and what are the problems?
Beatrix Schnorr, Ulrich Speck, Bruno Scheller
Editorial: Clinical Investigation
-
Drug-eluting balloons: where are we and what are the problems?
Beatrix Schnorr, Ulrich Speck, Bruno Scheller
Editorial: Clinical Investigation
-
Drug-eluting balloons: where are we and what are the problems?
Beatrix Schnorr, Ulrich Speck, Bruno Scheller
Editorial: Clinical Investigation
-
Drug-eluting balloons: where are we and what are the problems?
Beatrix Schnorr, Ulrich Speck, Bruno Scheller
Editorial: Clinical Investigation
-
Drug-eluting balloons: where are we and what are the problems?
Beatrix Schnorr, Ulrich Speck, Bruno Scheller
Editorial: Clinical Investigation
-
Drug-eluting balloons: where are we and what are the problems?
Beatrix Schnorr, Ulrich Speck, Bruno Scheller
Editorial: Clinical Investigation
-
Drug-eluting balloons: where are we and what are the problems?
Beatrix Schnorr, Ulrich Speck, Bruno Scheller
Editorial: Clinical Investigation
-
Drug-eluting balloons: where are we and what are the problems?
Beatrix Schnorr, Ulrich Speck, Bruno Scheller
Editorial: Clinical Investigation